Marika Harjula

Counsel, Brussels, Helsinki



Marika Harjula joined White & Case in March 2012 and is a member of the Brussels European law practice. She advises clients on a number of EU law issues with a particular focus on EU competition law.

Marika has represented clients before the European Commission in a number of Phase I and Phase II merger control reviews, including complex investigations requiring divestitures, and has also represented clients purchasing assets divested as part of the EU merger procedure. Marika regularly coordinates global merger filings and also advises on Finnish merger control. She has represented a number of clients before the Finnish Competition and Consumer Authority.

Marika also advises on cartel investigations, UK market investigations, abuse of dominance, horizontal and vertical agreements, and compliance. In addition to her competition law experience, Marika has experience with white collar work, financial regulatory work, litigation and arbitration.

Marika has advised companies active in a broad range of industries, including the financial sector, private equity, IT, automotive, consumer electronics, pharmaceuticals, medical devices, energy, chemicals, oil & gas, industrial and transport.

Marika has been on secondment to the firm's Paris and Singapore offices and often works in the Helsinki and London offices.  Prior to joining White & Case, Marika worked for a major international law firm in London and Brussels.

Bars and Courts
Solicitor of England and Wales
Brussels Bar
The College of Law, London
EU Business Law
University of Amsterdam
the Netherlands
Law and European Studies
University of Surrey


Representing Digital Realty on its $874 million acquisition of eight premium European data centers (sold as part of an EU divestment procedure).

Representing Continental AG, one of the leading automotive suppliers worldwide, on its €600 million acquisition of the automotive business of Nasdaq Helsinki-listed Elektrobit Corporation.

Representing Zimmer Holdings, a world leader in musculoskeletal health solutions, in obtaining merger clearance from the European Commission for its $13.35 billion acquisition of Biomet, Inc.

Representing a major European bank in connection with investigations by a large number of regulatory authorities globally.